Antipsychotic medicines cause obesity and diabetes

In 2008, roughly 14.3 million Americans were taking antipsychotics—typically prescribed for bipolar disorder, schizophrenia, or a number of other behavioral disorders—making them among the most prescribed drugs in the U.S. Almost all of these medications are known to cause the metabolic side effects of obesity and diabetes, leaving patients with a difficult choice between improving their mental health and damaging their physical health.

Read moreAntipsychotic medicines cause obesity and diabetes

Obesity :: Body-weight regulation scientists give perspective on obesity-related research

When obesity overloads the body with excess nutrients, parts start to fail. Obesity contributes to heart disease, stroke, diabetes, high blood pressure, some cancers, liver disease, immune dysfunction, painful joints, and a host of other problems. With so many parts of the body affected, studies of the health effects of obesity that concentrate on one body organ or system may overlook common underlying events occurring at the cellular level throughout the body.

Diabetes :: The new source of islet cells

The shortage of islet cells limits the development of islet transplantation. One new approach was reported in the October 21 issue of the World Journal of Gastroenterology because of its great significance in enhancing the output of islet cells. This article will undoubtedly bring benefit to diabetic patients.

Gene :: Genes that extend life and protect against cancer identified

A person is 100 times more likely to get cancer at age 65 than at age 35. But new research reported Oct. 14 in the journal Nature Genetics identifies naturally occurring processes that allow many genes to both slow aging and protect against cancer in the much-studied C. elegans roundworm.

Breast Cancer :: AACR, BCRF award inaugural grants in translational breast cancer research

Through the generous support of the Breast Cancer Research Foundation (BCRF), the American Association for Cancer Research (AACR) is pleased to announce the inaugural recipients of the 2007 BCRF-AACR Grants in Translational Breast Cancer Research. These grants provide direct support for innovative breast cancer research projects designed to accelerate the discovery, development, and application of new ways to treat breast cancer, or for preclinical research with direct therapeutic implications.

Do NOT follow this link or you will be banned from the site!